Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
about
The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?Drugs for improving esophageal mucosa defense: where are we now and where are we going?Editorial: refractory GERD-good drug, wrong patients? Authors' reply.Editorial: refractory GERD-good drug, wrong patients?
P2860
Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Randomised clinical trial: add ...... ts with breakthrough symptoms.
@en
Randomised clinical trial: addition of alginate-antacid
@nl
type
label
Randomised clinical trial: add ...... ts with breakthrough symptoms.
@en
Randomised clinical trial: addition of alginate-antacid
@nl
prefLabel
Randomised clinical trial: add ...... ts with breakthrough symptoms.
@en
Randomised clinical trial: addition of alginate-antacid
@nl
P2093
P2860
P356
P1476
Randomised clinical trial: add ...... ts with breakthrough symptoms.
@en
P2093
G Crawford
J Wilkinson
S J Thomas
P2860
P304
P356
10.1111/APT.14064
P407
P50
P577
2017-05-02T00:00:00Z